Aprea Therapeutics Statistics
Total Valuation
APRE has a market cap or net worth of $21.72 million. The enterprise value is -$10.69 million.
| Market Cap | 21.72M |
| Enterprise Value | -10.69M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, before market open.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
APRE has 5.43 million shares outstanding. The number of shares has increased by 28.76% in one year.
| Shares Outstanding | 5.43M |
| Shares Change (YoY) | +28.76% |
| Shares Change (QoQ) | +12.32% |
| Owned by Insiders (%) | 11.27% |
| Owned by Institutions (%) | 40.08% |
| Float | 4.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.54 |
| Forward PS | n/a |
| PB Ratio | 0.75 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.15, with zero debt.
| Current Ratio | 11.15 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 11.16 |
Financial Efficiency
Return on equity (ROE) is -56.80% and return on invested capital (ROIC) is -48.40%.
| Return on Equity (ROE) | -56.80% |
| Return on Assets (ROA) | -46.10% |
| Return on Capital (ROIC) | -48.40% |
| Revenue Per Employee | $137,686 |
| Profits Per Employee | -$1.82M |
| Employee Count | 7 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.96% in the last 52 weeks. The beta is 1.92, so APRE's price volatility has been higher than the market average.
| Beta (5Y) | 1.92 |
| 52-Week Price Change | +16.96% |
| 50-Day Moving Average | 4.53 |
| 200-Day Moving Average | 5.06 |
| Relative Strength Index (RSI) | 43.98 |
| Average Volume (20 Days) | 7,840 |
Short Selling Information
The latest short interest is 22,237, so 0.41% of the outstanding shares have been sold short.
| Short Interest | 22,237 |
| Short Previous Month | 19,639 |
| Short % of Shares Out | 0.41% |
| Short % of Float | 0.55% |
| Short Ratio (days to cover) | 1.81 |
Income Statement
In the last 12 months, APRE had revenue of $963,800 and -$12.72 million in losses. Loss per share was -$3.32.
| Revenue | 963,800 |
| Gross Profit | 963,800 |
| Operating Income | -14.00M |
| Pretax Income | -12.72M |
| Net Income | -12.72M |
| EBITDA | -13.96M |
| EBIT | -13.97M |
| Loss Per Share | -$3.32 |
Balance Sheet
The company has $32.41 million in cash and no debt, giving a net cash position of $32.41 million or $5.97 per share.
| Cash & Cash Equivalents | 32.41M |
| Total Debt | n/a |
| Net Cash | 32.41M |
| Net Cash Per Share | $5.97 |
| Equity (Book Value) | 28.92M |
| Book Value Per Share | 5.33 |
| Working Capital | 30.10M |
Cash Flow
In the last 12 months, operating cash flow was -$13.13 million and capital expenditures -$15,128, giving a free cash flow of -$13.15 million.
| Operating Cash Flow | -13.13M |
| Capital Expenditures | -15,128 |
| Free Cash Flow | -13.15M |
| FCF Per Share | -$3.13 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,452.49% and -1,319.46%.
| Gross Margin | 100.00% |
| Operating Margin | -1,452.49% |
| Pretax Margin | -1,319.46% |
| Profit Margin | -1,319.46% |
| EBITDA Margin | -1,447.94% |
| EBIT Margin | -1,449.27% |
| FCF Margin | -1,364.34% |
Dividends & Yields
APRE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.76% |
| Shareholder Yield | -28.76% |
| Earnings Yield | -58.55% |
| FCF Yield | -60.54% |
Analyst Forecast
The average price target for APRE is $15.50, which is 287.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.50 |
| Price Target Difference | 287.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 142.36% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Feb 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
APRE has an Altman Z-Score of -10.33 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.33 |
| Piotroski F-Score | 1 |